Results 61 to 67 of about 308 (67)

Automatically pre-screening patients for the rare disease aromatic l-amino acid decarboxylase deficiency using knowledge engineering, natural language processing, and machine learning on a large EHR population. [PDF]

J Am Med Inform Assoc
Cohen AM, Kaner J, Miller R, Kopesky JW, Hersh W.   +4 more
europepmc   +1 more source

Protecting the confidentiality of interim data: addressing current challenges. [PDF]

Clin Trials, 2015
Fleming TR.
europepmc   +1 more source

Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML.

Blood, 2017
Liyanage SU, Hurren R, Voisin V, Bridon G, Wang X, Xu C, MacLean N, Siriwardena TP, Gronda M, Yehudai D, Sriskanthadevan S, Avizonis D, Shamas-Din A, Minden MD, Bader GD, Laposa R, Schimmer AD.   +16 more
europepmc   +1 more source

Sex-based differences in short- and longer-term diet-induced metabolic heart disease.

Am J Physiol Heart Circ Physiol
Croft AJ, Kelly C, Chen D, Haw TJ, Balachandran L, Murtha LA, Boyle AJ, Sverdlov AL, Ngo DTM.   +8 more
europepmc   +1 more source

Chronic lysosome damage boosts interferon responses to Palbociclib dependent upon the mitochondrion

Bozic M, Lim TE, Salomó-Coll C, Karageorgiou A, Kemp AJ, Winnington-Ingram K, Murphy L, Dhir A, Wheeler A, Jimenez-Moreno N, Wilkinson S.   +10 more
europepmc   +1 more source

A Novel POR G88S Mutation Causes Severe PORD and Establishes a Critical Pharmacogenomic Risk Profile.

J Clin Endocrinol Metab
Rojas Velazquez MN, Lopez Dacal J, Jørgensen FS, Sanguineti N, Sharma K, Marino R, Pérez Garrido N, Vaiani E, Ramírez P, Scaglia P, Izquierdo A, Sansó G, Ropelato MG, Bergadá I, Rey RA, Grinspon RP, Pandey AV.   +16 more
europepmc   +1 more source